ScreenerHero

OSRH OSR Holdings Inc. Common Stock

Partial data
NAS · US · Healthcare · Biotechnology · osr-holdings.com
0.2199USD+24.24%Mkt Cap: 7.72M $P/E: —

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap7.72M USD
Enterprise Value33.28M USD
Revenue (TTM)1.81M USD
Gross Profit592.90K USD
Net Income (TTM)-18.01M USD
Revenue/Share0.06 USD
Last Price0.2199 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees22
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.49
EV/Revenue18.40
P/S4.80
P/B0.08
EPS (TTM)-0.27
EPS (Forward)—
52W Range
0.083017% of range0.9080
52W High0.9080 USD
52W Low0.0830 USD
Profitability
Gross Margin20.40%
Oper. Margin-960.79%
EBITDA Margin0.00%
Profit Margin-619.82%
ROE-23.20%
ROA-10.52%
Growth
Revenue Growth-72.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.33M USD
CapEx (TTM)176.38K USD
FCF Margin-148.14%
FCF Yield-34.70%
Net Debt3.96M USD
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity0.06
Current Ratio0.18
Quick Ratio0.11
Book Value/Sh2.97 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)10.00 USD
Upside (mean)+4447.5%
Target Range10.00 USD – 10.00 USD
# Analysts1
Ownership
Shares Out.35.12M
Float14.57M
Insiders0.07%
Institutions0.43%
Short Interest
Short Ratio1.4d
Short % Float9.10%
Short % Out.3.48%
Shares Short1.22M
Short (prev mo.)1.69M
Technical
SMA 500.3097 (-29.0%)
SMA 2000.4626 (-52.5%)
Beta0.50
S&P 52W Chg13.94%
Avg Vol (30d)14.58M
Avg Vol (10d)302.37K
Technical Indicators
RSI (14)45.0
MACD-0.0506
MACD Signal-0.0486
MACD Hist.-0.0020
BB Upper0.4607 USD
BB Middle0.2585 USD
BB Lower0.0563 USD
BB Width156.46%
ATR (14)0.0746 USD
Vol Ratio (20d)0.00x